SCHEMBL14829622

SCHEMBL14829622

C[C@H]1CCC[C@@](C)(N)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL660884 1.00
SCHEMBL19262991 1.00
SCHEMBL466087 1.00
SCHEMBL225338 1.00
Fluoride SCHEMBL5765589 0.98 CYP1A2 (0.38)
Hydrochloric Acid SCHEMBL907007 0.98 CYP1A2 (0.38)
Hydrochloric Acid SCHEMBL907008 0.98 CYP1A2 (0.38)
SCHEMBL24892642 0.93 CYP1A2 (0.34)
SCHEMBL21782559 0.91 CYP1A2 (0.33)
SCHEMBL4168216 0.84

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2760447-A1 ANTIVIRAL THERAPIES WITH PHOSPHOLIPASE D INHIBITORS Vanderbilt University (US) 2014-08-06 EP disclosed
WO-2013049773-A1 ANTIVIRAL THERAPIES WITH PHOSPHOLIPASE D INHIBITORS VANDERBILT UNIVERSITY (US) 2013-04-04 WO disclosed